Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
Jaime Landman MD, Director of Minimally Invasive Urology at Columbia Medical Center discusses Cytoreductive Nephrectomy, the cutting edge of kidney cancer management for patients whose disease is not…
NEW YORK (Reuters Health) – Vitamin D deficiency is “rampant” among children with chronic kidney disease, and the prevalence of severe deficiency has increased over the last two…
NEW YORK (Reuters Health) – Reducing blood pressure with the drug combination perindopril-indapamide reduces renal events in patients with type 2 diabetes, even when the initial blood pressure…
NEW YORK (Reuters Health) – In patients with diffuse cutaneous systemic sclerosis (dcSSc), treatment with rituximab depletes B cells in the peripheral circulation and in skin, with few…
NEW YORK (Reuters Health) – Educating patients with end-stage renal disease (ESRD) to avoid processed and fast foods prepared with phosphorus-containing additives results in clinically significant improvements in…
NEW YORK (Reuters Health) – Pulse pressure can be used to screen patients with chronic kidney disease to identify those with coronary artery calcification who need further evaluation,…
NEW YORK (Reuters Health) – One reason that African Americans have high rates of renal failure is that earlier, treatable stages of kidney disease are not being recognized…
NEW YORK (Reuters Health) – Carefully selected kidney donors can expect to live just as long as people in the general population and experience no significant drop in…
NEW YORK (Reuters Health) – US researchers have developed a clinical equation that may enhance the estimation of glomerular filtration rate (GFR) in children with chronic kidney disease,…
NEW YORK (Reuters Health) – Long-term treatment of systemic lupus erythematosus (SLE) with hydroxychloroquine, initiated soon after disease onset, is protective against renal damage, according to study findings…
